Advertisement

Ophthalmology

Eye health company Bausch + Lomb, based in Rochester, N.Y., announced it had begun the third phase of testing for latanoprostene bunod, a drug it is licensing from Paris-based Nicox for experimental use in patients with glaucoma or ocular hypertension.

Rates of post-operative endophthalmitis have lowered to a range between 0.03 percent and 0.15 percent, according to a presentation by Andrew Moshfeghi, MD, a physician and consultant speaking at the Hawaiian Eye 2013 conference in Waikoloa, Hawaii.

Genetic mutations that can cause inherited glaucoma can be discovered through early genetic testing, according to a speaker at the Hawaiian Eye 2013 conference in Waikoloa, as reported by Ocular Surgery News.

Patient satisfaction and efficiency were not negatively impacted after an ophthalmology clinic implemented an EHR system, according to a study published by the American Academy of Ophthalmology's journal Ophthalmology.

Advertisement

Cataract surgeons will see a 12 to 25 percent decrease in RVUs for cataract surgery, but some cuts will be less than originally believed, according to healthcare consultant Donna McCune speaking at an ophthalmology conference in Hawaii.

Regular aspirin may be linked with the development of age-related macular degeneration, according to a 15-year Australian prospective study published in JAMA Internal Medicine.

Seattle-based pharmaceutical company Omeros announced positive results from its final Phase 3 clinical trial of OMS302, a drug added to irrigation solutions after cataract or lens replacement surgery.

Reimbursement cuts and changing delivery models were among the topics discussed by panelists at the joint meeting for the American Academy of Ophthalmology and Asia-Pacific Academy of Ophthalmology in Chicago, according to a report by Ocular Surgery News.

Advertisement